Abstract:Abstract Disrupted host-microbe interactions at the mucosal level are key to the pathophysiology of IBD. This study aimed to comprehensively examine crosstalk between mucosal gene expression and microbiota in patients with IBD. To study tissue-specific interactions, we perform transcriptomic (RNA-seq) and microbial (16S-rRNA-seq) profiling of 697 intestinal biopsies (645 derived from 335 patients with IBD and 52 from 16 non-IBD controls). Mucosal gene expression patterns in IBD are mainly determined by tissue location and inflammation, whereas the mucosal microbiota composition shows a high degree of individual specificity. Analysis of transcript-bacteria interactions identifies six distinct groups of inflammation-related pathways that are associated with intestinal microbiota (adjusted P < 0.05). An increased abundance of Bifidobacterium is associated with higher expression of genes involved in fatty acid metabolism, while Bacteroides correlates with increased metallothionein signaling. In patients with fibrostenosis, a transcriptional network dominated by immunoregulatory genes is associated with Lachnoclostridium bacteria in non-stenotic tissue (adjusted P < 0.05), while being absent in CD without fibrostenosis. In patients using TNF-α-antagonists, a transcriptional network dominated by fatty acid metabolism genes is linked to Ruminococcaceae (adjusted P < 0.05). Mucosal microbiota composition correlates with enrichment of intestinal epithelial cells, macrophages, and NK-cells. Overall, these data demonstrate the presence of context-specific mucosal host-microbe interactions in IBD, revealing significantly altered inflammation-associated gene-taxa modules, particularly in patients with fibrostenotic CD and patients using TNF-α-antagonists. This study provides compelling insights into host–microbe interactions that may guide microbiota-directed precision medicine and fuels the rationale for microbiota-targeted therapeutics as a strategy to alter disease course in IBD.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the specific mechanisms of mucosal host - microbe interactions in inflammatory bowel disease (IBD) and their associations with clinical phenotypes. Specifically, the study aims to comprehensively examine the interactions between mucosal gene expression and the microbiota in IBD patients to reveal how these interactions affect the development and progression of the disease. ### Research Background Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is a chronic intestinal inflammatory disease. The pathogenesis of IBD is caused by complex interactions among genetic factors, environmental factors, the gut microbiota, and the host immune system. The composition and function of the gut microbiota are often altered in IBD patients, such as decreased microbial diversity, reduced butyrate - producing bacteria, and an increased proportion of pathogenic bacteria. ### Research Objectives 1. **Comprehensive analysis of the interactions between mucosal gene expression and the microbiota**: Analyze 697 intestinal biopsy samples through transcriptomics (RNA - seq) and microbiomics (16S rRNA - seq), of which 645 are from 335 IBD patients and 52 are from 16 non - IBD control groups. 2. **Explore mucosal host - microbe interactions under different clinical phenotypes**: Investigate the effects of factors such as tissue location, inflammatory state, disease subtype (CD vs. UC), and drug use (such as TNF - α antagonists) on mucosal gene expression and the microbiota. 3. **Identify gene - bacteria modules associated with specific clinical phenotypes**: Identify gene - bacteria interaction networks associated with specific clinical phenotypes (such as fibrostenotic CD and TNF - α antagonist users) through methods such as sparse canonical correlation analysis (sparse - CCA) and central local connectivity analysis (centrLCC). ### Main Findings 1. **Mucosal gene expression patterns are mainly determined by tissue location and inflammatory state**: PCA analysis shows that the first two principal components can significantly distinguish tissue location (ileum vs. colon), inflammatory state (non - inflammatory vs. inflammatory), and disease subtype (CD vs. UC). 2. **The composition of the mucosal microbiota is highly individual - specific**: The Shannon diversity index shows that the microbial diversity in CD patients is significantly lower than that in UC patients and non - IBD control groups. The inter - individual differences in the microbiota are greater than the effects of tissue location or inflammatory state. 3. **Six gene - bacteria modules related to inflammation are identified**: These modules are involved in pathways such as fatty acid metabolism, metallothionein signaling, and immunomodulation. 4. **Fibrostenotic CD patients exhibit gene networks related to Lachnoclostridium**: These genes are mainly involved in cell activation pathways. 5. **TNF - α antagonist users exhibit gene networks related to Ruminococcaceae**: These genes are mainly involved in fatty acid metabolism. ### Significance This study provides an in - depth understanding of mucosal host - microbe interactions in IBD, reveals gene - bacteria modules under specific clinical phenotypes, provides a theoretical basis for microbe - targeted precision medicine, and helps develop new treatment strategies to change the course of IBD.

Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

Interplay of Intestinal Microbiota and Mucosal Immunity in Inflammatory Bowel Disease: a Relationship of Frenemies

Mucosal Genes Expression in Inflammatory Bowel Disease Patients: New Insights

Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease

Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD

Integrative Multi-Omics Deciphers the Spatial Characteristics of Host-Gut Microbiota Interactions in Crohn’s Disease

P913 Interactions between Intestinal Microbiota and micro-RNAs in Inflammatory Bowel Disease

Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease

Inferring intestinal mucosal immune cell associated microbiome species and microbiota-derived metabolites in inflammatory bowel disease

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort

Gut microbiota signatures in inflammatory bowel disease

Gut microbiome structure and metabolic activity in inflammatory bowel disease

Exploring the intestinal ecosystem: from gut microbiota to associations with subtypes of inflammatory bowel disease

The biogeography of the mucosa-associated microbiome in health and disease

DOP26 Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohort

Bacterial microbiome profiles of the inflamed terminal ileum mucosa in active Crohn’s disease patients

Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment